← Mechanisms of action
SARS-CoV-2
ORGANISMHomo sapiens
Drugs acting on this target (112)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| apo-si-k170a-c76 | Antisense inhibitor | experimental | Nucleic acid | SARS-CoV-2 antisense inhibitor |
| double-stranded rna sodium salt | Antisense inhibitor | experimental | Nucleic acid | antisense inhibitor - sars-cov-2 |
| mbs-cov | Antisense inhibitor | experimental | Nucleic acid | antisense inhibitor - sars-cov-2 |
| abo1009-dp | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| ad5-ncov vaccine | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| alveavax-v1.2 | Immunity, active | experimental | Vaccine | immunity, active - SARS-Cov-2 |
| arct-2303 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| arvac-cg | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| azd9838 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| boost-2867 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| cd40.pan.cov | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| cd40.rbdv vaccin | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| chadox1-pcaq | Immunity, active | experimental | Vaccine | immunity, active - sars-cov-2 |
| Coronavirus-Like Particle COVID-19 Vaccine | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| cov-rbd-scnp-001 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covid-19 vaccine, mrna (Comirnaty) | Immunity, active | approved | Vaccine | SARS-CoV-2 immunity, active |
| cpg55.2 | Immunity, active | experimental | Vaccine | immunity, active - sars-cov-2 |
| cv0601 | Immunity, active | experimental | Vaccine | immunity, active - sars-cov-2 |
| cv09050101 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| cvxga | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| finlay-fr-1a | Immunity, active | experimental | Vaccine | immunity, active - sars-cov-2 |
| g0302-covid19 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| gam-covid-vac (rad26) | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| gam-covid-vac (rad5) | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| glycovax-002 | Immunity, active | experimental | Vaccine | immunity, active - Sars-cov-2 |
| iccov | Immunity, active | experimental | Vaccine | immunity, active - sars-cov-2 |
| icp-ni | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| imnn-101 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| jcxh-221 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| lem-mr203 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| lvrna021 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| lvt-001 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| lyb002 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| mpv/s-2p | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mrna-cr-04 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| nvx-cov2372 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| nvx-cov2601 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| oc-007 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| ovx033 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| qtp104 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| rbmrna-405 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| rc19 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| recombinant covid-19 vaccine (chimpanzee adenovirus vector) | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| rq3025 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| rq3027 | Immunity, active | experimental | Vaccine | immunity, active - Sars-cov-2 |
| rvm-v002 | Immunity, active | experimental | Vaccine | immunity, active - sars-cov-2 |
| sars-cov-2 mrna vaccine, bivalent | Immunity, active | experimental | Vaccine | immunity, active - Sars-COV-2 |
| scb-2023 | Immunity, active | experimental | Vaccine | immunity, active - sars-cov-2 |
| swim816 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| tak-019 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| ti-0010 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| uqsc2 | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| vidprevtyn | Immunity, active | experimental | Vaccine | immunity, active - SARS-CoV-2 |
| vxco-100 | Immunity, active | experimental | Vaccine | immunity, active - sars-cov-2 |
| zsvg-02 | Immunity, active | experimental | Vaccine | immunity, active - Sars-cov-2 |
| abbv-47d11 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| adm03820 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| anti sars-cov-2 equine hyperimmune serum | Immunity, passive | experimental | Animal product | immunity, passive - SARS-CoV-2 |
| anti-sars-cov-2 igy | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| bgb dxp593 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| bgb-dxp604 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| brii-196 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| brii-198 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| covi-amg | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| ct-p59 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| descartes 30 | Immunity, passive | experimental | Cell therapy | immunity, passive - sars-cov-2 |
| dzif-10c | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| hfb30132a | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| hlx70 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| js016 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| ly3819253 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| ly3832479 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| monoclonal antibody cal | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| mw05 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| mw33 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| rapa-501-allo | Immunity, passive | experimental | Cell therapy | immunity, passive - sars-cov-2 |
| regdanvimab (Regkirona) | Immunity, passive | experimental | mAb | immunity, passive - sars-cov-2 |
| regn10933 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| regn10987 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| regn17092 | Immunity, passive | experimental | mAb | immunity, passive - SARS-COv-2 |
| sa58 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| scta01 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| sti-1499 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| ty027 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| vir-7831 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| xvr011 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| a8g6 | Inhibitor | experimental | mAb | inhibitor - SARS-CoV-2 |
| aer002 | Inhibitor | experimental | mAb | inhibitor - sars-cov-2 |
| bat2020 | Inhibitor | experimental | Small molecule | inhibitor - SARS-CoV-2 |
| bat2022 | Inhibitor | experimental | mAb | inhibitor - SARS-CoV-2 |
| Codivir | Inhibitor | experimental | Peptide | inhibitor - SARS-CoV-2 |
| gamcovimab | Inhibitor | experimental | mAb | inhibitor - SARS-COV-2 |
| gb-0669 | Inhibitor | experimental | mAb | SARS-CoV-2 inhibitor |
| hc010 | Inhibitor | experimental | mAb | SARS-CoV-2 inhibitor |
| hh-120 | Inhibitor | experimental | Recombinant protein | inhibitor - SARS-CoV-2 |
| hl237 | Inhibitor | experimental | mAb | inhibitor - SARS-CoV-2 |
| lmn-301 | Inhibitor | experimental | Botanical | inhibitor - SARS-CoV-2 |
| mCBM40 | Inhibitor | experimental | Biological | SARS-CoV-2 inhibitor |
| Mindeudesivir | Inhibitor | experimental | Small molecule | inhibitor - SARS-CoV-2 |
| my-586 | Inhibitor | experimental | mAb | inhibitor - SARS-CoV-2 |
| nab001 | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| pdi204 | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| Phillyrin | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| pjs-539 | Inhibitor | experimental | Small molecule | inhibitor - SARS-CoV-2 |
| sa55 | Inhibitor | experimental | mAb | inhibitor - sars-cov-2 |
| si-f019 | Inhibitor | experimental | Recombinant protein | inhibitor - SARS-CoV-2 |
| sipavibart | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| stsa-1005 | Inhibitor | experimental | Small molecule | inhibitor - SARS-CoV-2 |
| tmb-607 | Inhibitor | experimental | Small molecule | inhibitor - SARS-CoV-2 |
| vyd222 | Inhibitor | experimental | mAb | inhibitor - SARS-CoV-2 |
| vyd2311 | Inhibitor | experimental | mAb | SARS-CoV-2 inhibitor |
| wpv01 | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |